Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Results may vary due to individual factors
It reached Phase II clinical trials for GH deficiency and short stature in children but was not advanced to market
Currently, there are limited therapeutic options for the disease because of limited understanding of its molecular mechanism
UCSF ChimeraX: tools for structure building and analysis
Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials
US$ 27.52
US$ 20.86
US$ 22.82
US$ 21.30
US$ 29.54
